Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-23-019412

CEO and President gave up 3,584 shares (to pay taxes)

  • CEO and President acquired 14,717 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KLEMP WALTER V · CEO and President

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-02 Exercise or conversion : show line 1 in the form +14,717 486,072 D
2023-07-02 Shares withheld for taxes : show line 2 in the form −3,584 $0.58 $2,074 482,488 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-07-02 Exercise or conversion : show line 3 in the form Restricted Stock Units −14,717 1,941,349 D
Loading xslF345X04/rdgdoc.xml…